Target Price | CHF301.79 |
Price | CHF257.00 |
Potential | 17.43% |
Number of Estimates | 19 |
19 Analysts have issued a price target Roche 2025 . The average Roche target price is CHF301.79. This is 17.43% higher than the current stock price. The highest price target is CHF440.00 71.21% , the lowest is CHF230.00 10.51% . | |
A rating was issued by 22 analysts: 9 Analysts recommend Roche to buy, 9 to hold and 4 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Roche stock has an average upside potential 2025 of 17.43% . Most analysts recommend the Roche stock at Buy or hold. |
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Billion CHF | 58.72 | 60.69 |
7.21% | 3.36% | |
EBITDA Margin | 33.76% | 38.26% |
2.89% | 13.33% | |
Net Margin | 19.53% | 21.82% |
0.14% | 11.74% |
18 Analysts have issued a sales forecast Roche 2024 . The average Roche sales estimate is CHF60.7b . This is 3.24% higher than the revenue of the last 12 months(TTM). The highest sales forecast is CHF63.3b 7.73% , the lowest is CHF59.7b 1.48% .
This results in the following potential growth metrics:
2023 | CHF58.7b | 7.21% |
---|---|---|
2024 | CHF60.7b | 3.36% |
2025 | CHF64.3b | 5.87% |
2026 | CHF67.1b | 4.36% |
2027 | CHF70.1b | 4.49% |
2028 | CHF72.1b | 2.94% |
16 Analysts have issued an Roche EBITDA forecast 2024. The average Roche EBITDA estimate is CHF23.2b . This is 17.02% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is CHF25.8b 29.87% , the lowest is CHF20.4b 2.58% .
This results in the following potential growth metrics and future EBITDA Margins:
2023 | CHF19.8b | 9.89% |
---|---|---|
2024 | CHF23.2b | 17.14% |
2025 | CHF25.1b | 8.24% |
2026 | CHF26.4b | 5.07% |
2027 | CHF27.7b | 4.88% |
2028 | CHF28.3b | 2.34% |
2023 | 33.76% | 2.89% |
---|---|---|
2024 | 38.26% | 13.33% |
2025 | 39.12% | 2.25% |
2026 | 39.38% | 0.66% |
2027 | 39.53% | 0.38% |
2028 | 39.30% | 0.58% |
14 Roche Analysts have issued a net profit forecast 2024. The average Roche net profit estimate is CHF13.2b . This is 24.78% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF15.0b 41.36% , the lowest is CHF11.5b 8.41% .
This results in the following potential growth metrics and future Net Margins:
2023 | CHF11.5b | 7.34% |
---|---|---|
2024 | CHF13.2b | 15.50% |
2025 | CHF15.1b | 13.90% |
2026 | CHF16.2b | 7.14% |
2027 | CHF17.0b | 5.48% |
2028 | CHF17.9b | 5.19% |
2023 | 19.53% | 0.14% |
---|---|---|
2024 | 21.82% | 11.74% |
2025 | 23.48% | 7.61% |
2026 | 24.10% | 2.64% |
2027 | 24.33% | 0.95% |
2028 | 24.86% | 2.18% |
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share CHF | 14.39 | 16.62 |
7.34% | 15.50% | |
P/E | 15.46 | |
EV/Sales | 3.86 |
14 Analysts have issued a Roche forecast for earnings per share. The average Roche <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is CHF16.62 . This is 24.77% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is CHF18.83 41.37% , the lowest is CHF14.44 8.41% .
This results in the following potential growth metrics and future valuations:
2023 | CHF14.39 | 7.34% |
---|---|---|
2024 | CHF16.62 | 15.50% |
2025 | CHF18.93 | 13.90% |
2026 | CHF20.28 | 7.13% |
2027 | CHF21.39 | 5.47% |
2028 | CHF22.50 | 5.19% |
Current | 19.29 | 11.12% |
---|---|---|
2024 | 15.46 | 19.85% |
2025 | 13.58 | 12.16% |
2026 | 12.67 | 6.70% |
2027 | 12.01 | 5.21% |
2028 | 11.42 | 4.91% |
Based on analysts' sales estimates for 2024, the Roche stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 3.86 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 3.37 .
This results in the following potential growth metrics and future valuations:
Current | 3.99 | 13.68% |
---|---|---|
2024 | 3.86 | 3.23% |
2025 | 3.65 | 5.54% |
2026 | 3.49 | 4.18% |
2027 | 3.34 | 4.30% |
2028 | 3.25 | 2.86% |
Current | 3.48 | 10.62% |
---|---|---|
2024 | 3.37 | 3.14% |
2025 | 3.19 | 5.54% |
2026 | 3.05 | 4.18% |
2027 | 2.92 | 4.30% |
2028 | 2.84 | 2.85% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.